Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bristol-Myers Squibb

This article was originally published in The Rose Sheet

Executive Summary

Haircoloring products "performed well" during the third quarter, the company says in its financial report for the quarter, noting "strong sales" of Nice'n Easy and Miss Clairol, as well as the U.S. introduction of Natural Instincts. BMS consolidated worldwide sales gained 2.4% to $2.93 bil. in the third quarter, with a 6% increase in international sales and flat domestic sales. Net earnings for the quarter increased 2.1% to $620.8 mil. For the nine months, consolidated sales grew 3.8% to $8.74 bil.; there was a 4% increase in domestic sales and a 3% gain in international sales during the three months. Nine-months earnings advanced 2.4% to $1.74 bil

Latest Headlines
See All
UsernamePublicRestriction

Register

RS000996

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel